- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Elbit reports lower ultrasound sales
Elbit Medical Imaging of Haifa, Israel, reported that sales in its Elbit Ultrasound unit were $182.4 million for its 1997 fiscal year (end-December), down 13% compared with revenues of $208.9 million in 1996. For the fourth quarter, the division had
Elbit Medical Imaging of Haifa, Israel, reported that sales in its Elbit Ultrasound unit were $182.4 million for its 1997 fiscal year (end-December), down 13% compared with revenues of $208.9 million in 1996. For the fourth quarter, the division had revenues of $58.6 million, compared with $63.6 million in the fourth quarter of 1996, a decline of 8%.
Elbit said the reduction in the ultrasound division's revenues was primarily due to the discontinuation of sales of Hitachi Ultrasound products, which Elbit Ultrasound distributed until December 1996. Sales of Hitachi products contributed $32 million to Elbit Ultrasound's revenues in 1996.
The ultrasound division is composed of Diasonics Vingmed Ultrasound, which Elbit has agreed to sell to GE Medical Systems (SCAN 3/4/98). Elbit said it continues to work on GE's proposal to acquire Diasonics Vingmed, and hopes to have a final agreement signed by the end of March.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
